These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34669958)

  • 21. Lipid Nanoparticle-Enabled Intracellular Delivery of Prime Editors.
    Herrera-Barrera M; Gautam M; Lokras A; Vlasova K; Foged C; Sahay G
    AAPS J; 2023 Jun; 25(4):65. PubMed ID: 37380935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PEAR, a flexible fluorescent reporter for the identification and enrichment of successfully prime edited cells.
    Simon DA; Tálas A; Kulcsár PI; Biczók Z; Krausz SL; Várady G; Welker E
    Elife; 2022 Feb; 11():. PubMed ID: 35196219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PE-STOP: A versatile tool for installing nonsense substitutions amenable for precise reversion.
    Song Z; Zhang G; Huang S; Liu Y; Li G; Zhou X; Sun J; Gao P; Chen Y; Huang X; Liu J; Wang X
    J Biol Chem; 2023 Aug; 299(8):104942. PubMed ID: 37343700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional Vector for Delivery of Genome Editing Plasmid Targeting β-Catenin to Remodulate Cancer Cell Properties.
    He XY; Liu BY; Peng Y; Zhuo RX; Cheng SX
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):226-237. PubMed ID: 30540162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing.
    Sinclair F; Begum AA; Dai CC; Toth I; Moyle PM
    Drug Deliv Transl Res; 2023 May; 13(5):1500-1519. PubMed ID: 36988873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenovirus as an integrating vector.
    Mitani K; Kubo S
    Curr Gene Ther; 2002 May; 2(2):135-44. PubMed ID: 12109211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How Various Drug Delivery Methods Could Aid in the Translation of Genome Prime Editing Technologies.
    Ivanova E
    Genet Res (Camb); 2022; 2022():7301825. PubMed ID: 35283690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivery of CRISPR/Cas9 for therapeutic genome editing.
    Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
    J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential of CRISPR-Cas9 prime editing for cardiovascular disease research and therapy.
    Bharucha N; Arias A; Karakikes I
    Curr Opin Cardiol; 2022 Sep; 37(5):413-418. PubMed ID: 35880456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A normothermic ex vivo organ perfusion delivery method for cardiac transplantation gene therapy.
    Bishawi M; Roan JN; Milano CA; Daneshmand MA; Schroder JN; Chiang Y; Lee FH; Brown ZD; Nevo A; Watson MJ; Rowell T; Paul S; Lezberg P; Walczak R; Bowles DE
    Sci Rep; 2019 May; 9(1):8029. PubMed ID: 31142753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-step gene transfer using an adenoviral vector carrying the CD4 gene and human immunodeficiency viral vectors.
    Miyake K; Tohyama T; Shimada T
    Hum Gene Ther; 1996 Dec; 7(18):2281-6. PubMed ID: 8953319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of efficiencies for diverse prime editing systems in multiple cell types.
    Yu G; Kim HK; Park J; Kwak H; Cheong Y; Kim D; Kim J; Kim J; Kim HH
    Cell; 2023 May; 186(10):2256-2272.e23. PubMed ID: 37119812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive analysis of prime editing outcomes in human embryonic stem cells.
    Habib O; Habib G; Hwang GH; Bae S
    Nucleic Acids Res; 2022 Jan; 50(2):1187-1197. PubMed ID: 35018468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
    Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
    Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production.
    Baldassarri S; Benati D; D'Alessio F; Patrizi C; Cattin E; Gentile M; Raggioli A; Recchia A
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver targeted gene therapy: Insights into emerging therapies.
    Moscoso CG; Steer CJ
    Drug Discov Today Technol; 2019 Dec; 34():9-19. PubMed ID: 33357766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo prime editing of a metabolic liver disease in mice.
    Böck D; Rothgangl T; Villiger L; Schmidheini L; Matsushita M; Mathis N; Ioannidi E; Rimann N; Grisch-Chan HM; Kreutzer S; Kontarakis Z; Kopf M; Thöny B; Schwank G
    Sci Transl Med; 2022 Mar; 14(636):eabl9238. PubMed ID: 35294257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic gene editing: delivery and regulatory perspectives.
    Shim G; Kim D; Park GT; Jin H; Suh SK; Oh YK
    Acta Pharmacol Sin; 2017 Jun; 38(6):738-753. PubMed ID: 28392568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy.
    March KL; Madison JE; Trapnell BC
    Hum Gene Ther; 1995 Jan; 6(1):41-53. PubMed ID: 7703286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of a more efficient prime editor 2 by addition of the Rad51 DNA-binding domain.
    Song M; Lim JM; Min S; Oh JS; Kim DY; Woo JS; Nishimasu H; Cho SR; Yoon S; Kim HH
    Nat Commun; 2021 Sep; 12(1):5617. PubMed ID: 34556671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.